DiaMedica Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| COOPERMAN LEON G | 11/14/2024 | 1.51 M | $6.33 M | 7.98% | 3.54% |
| VANGUARD GROUP INC | 11/13/2024 | 1.05 M | $4.40 M | 3.11% | 2.45% |
| FIRST MANHATTAN CO. LLC. | 11/14/2024 | 839,081 | $3.52 M | 0.00% | 1.96% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 11/14/2024 | 482,614 | $2.02 M | 0.00% | 1.13% |
| BLEICHROEDER LP | 11/13/2024 | 382,317 | $1.60 M | 0.00% | 0.89% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 306,958 | $1.29 M | 29.58% | 0.72% |
| LPL FINANCIAL LLC | 11/08/2024 | 140,500 | $588,695 | 702.86% | 0.33% |
| MORGAN STANLEY | 11/14/2024 | 110,016 | $460,967 | 27.63% | 0.26% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 107,790 | $451,639 | 100.00% | 0.25% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 101,450 | $425,076 | 133.90% | 0.24% |
| STATE STREET CORP | 11/14/2024 | 68,729 | $287,975 | 0.00% | 0.16% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 52,089 | $218,253 | 100.00% | 0.12% |
| RONALD BLUE TRUST, INC. | 10/17/2024 | 44,247 | $130,529 | 100.00% | 0.10% |
| CATALYST FINANCIAL PARTNERS LLC | 10/28/2024 | 38,457 | $161,135 | 0.00% | 0.09% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 33,690 | $141,161 | 100.00% | 0.08% |
| JEFFERIES FINANCIAL GROUP INC. | 11/14/2024 | 26,000 | $108,940 | 100.00% | 0.06% |
| STONEBRIDGE CAPITAL ADVISORS LLC | 11/14/2024 | 17,500 | $73,325 | -12.50% | 0.04% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 16,959 | $71,058 | 0.00% | 0.04% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 13,251 | $55,522 | 0.00% | 0.03% |
| UBS GROUP AG | 11/14/2024 | 12,739 | $53,376 | 100.00% | 0.03% |
| CITADEL ADVISORS LLC | 11/14/2024 | 11,831 | $49,572 | 40.63% | 0.03% |
| RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC. | 10/18/2024 | 11,520 | $48,269 | 100.00% | 0.03% |
| MAGNOLIA CAPITAL ADVISORS LLC | 10/30/2024 | 10,000 | $41.90 M | 0.00% | 0.02% |
| POINT72 ASIA (SINGAPORE) PTE. LTD. | 11/14/2024 | 9,498 | $39,797 | 100.00% | 0.02% |
| CITADEL ADVISORS LLC | 11/14/2024 | 8,200 | $34,358 | 530.77% | 0.02% |
| MASSMUTUAL TRUST CO FSB/ADV | 10/02/2024 | 4,824 | $20,213 | 0.00% | 0.01% |
| US BANCORP \DE\ | 10/28/2024 | 4,335 | $18,164 | 0.00% | 0.01% |
| SIMPLEX TRADING, LLC | 11/08/2024 | 3,662 | $15,000 | 100.00% | 0.01% |
| CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 3,263 | $13,672 | 100.00% | 0.01% |
| NAPLES MONEY MANAGEMENT LLC | 11/12/2024 | 2,068 | $8,665 | -30.56% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 11/14/2024 | 1,118 | $4,684 | -40.78% | 0.00% |
| TD WATERHOUSE CANADA INC. | 11/12/2024 | 1,070 | $4,449 | 0.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 11/13/2024 | 1,055 | $4,420 | -48.66% | 0.00% |
| LEGEND FINANCIAL ADVISORS, INC. | 10/18/2024 | 1,000 | $4,190 | 0.00% | 0.00% |
| ROYAL BANK OF CANADA | 11/14/2024 | 805 | $3,000 | -23.77% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11/14/2024 | 213 | $892 | 16.39% | 0.00% |
| CITADEL ADVISORS LLC | 11/14/2024 | 200 | $838 | -80.00% | 0.00% |
| CORNERSTONE PLANNING GROUP LLC | 11/05/2024 | 80 | $346 | 100.00% | 0.00% |
| JPMORGAN CHASE & CO | 11/08/2024 | 27 | $113 | 100.00% | 0.00% |
| TORONTO DOMINION BANK | 11/18/2024 | 0 | $0 | -100.00% | 0.00% |
| ARISTIDES CAPITAL LLC | 11/14/2024 | 0 | $0 | -100.00% | 0.00% |
| JANE STREET GROUP, LLC | 11/15/2024 | 0 | $0 | -100.00% | 0.00% |
| FEDERATION DES CAISSES DESJARDINS DU QUEBEC | 11/13/2024 | 0 | $0 | -100.00% | 0.00% |
DiaMedica Therapeutics Inc.institutional Ownership - FAQ's
During the previous two years, 43 institutional investors and hedge funds held shares of DiaMedica Therapeutics Inc.. The most heavily invested institutionals were:
COOPERMAN LEON G: 1.51 M
VANGUARD GROUP INC: 1.05 M
FIRST MANHATTAN CO. LLC.: 839,081
PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE: 482,614
Bleichroeder LP: 382,317
GEODE CAPITAL MANAGEMENT, LLC: 306,958
13.05% of DiaMedica Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 5.70 M shares in the last 24 months. This purchase volume represents approximately $29.96 M in transactions.